Highly mutated cancers respond better to immune therapy

Highly mutated cancers respond better to immune therapy, Published online: 14 January 2019; doi:10.1038/d41586-019-00143-8

The complex tests that gauge mutation levels will pose a challenge in the clinic. http://feeds.nature.com/nature/rss/current via https://www.nature.com/articles/d41586-019-00143-8

Advertisements